T-cell Therapy Market Size, Share & Trends Report

T-cell Therapy Market Size, Share & Trends Analysis Report By Modality, By Therapy (CAR T-cell, Tumor-Infiltrating Lymphocytes), By Indication (Hematologic Malignancies (Lymphoma)), And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-3-68038-685-1
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Table of Content

Chapter 1 T-cell Therapy Market: Research Methodology
                   1.1 Information Procurement
                   1.2 Information or Data Analysis
                   1.3 Market Formulation & Validation
Chapter 2 T-cell Therapy Market: Executive Summary
                   2.1 Competition Milieu
                   2.2 Market Snapshot
                   2.3 Segment Outlook
Chapter 3 T-cell Therapy Market: Variables, Trends, & Scope
                   3.1 Market Lineage Outlook
                   3.2 T-Cell Therapy- Market Dynamics
                       3.2.1 Market driver analysis
                           3.2.1.1 Rising investment in adoptive T cell transfer approaches of disease treatment
                           3.2.1.2 Growing competition among market players
                           3.2.1.3 Approval of Kymriah and Yescarta across various countries
                           3.2.1.4 Developments in CAR T-cell therapy for solid tumors
                           3.2.1.5 Technological advancements in manufacturing process
                       3.2.2 Market restraint analysis
                           3.2.2.1 Regulatory, scientific, and ethical challenges associated with gene therapy
                           3.2.2.2 High prices of therapies
                           3.2.2.3 CAR T limitations
                       3.2.3 Opportunity analysis
                           3.2.3.1 Facility expansion for cell and gene therapies
                           3.2.3.3 Rising global financings in gene and cell therapy arena
                           3.2.3.3 Ongoing developments in viral & non-viral vector manufacturing arena
                   3.3 Industry Analysis Tools
                       3.3.1 Porter's Five Forces Analysis
                       3.3.2 PESTEL Analysis
                       3.3.3 COVID-19 Impact Analysis
                   3.4 Pipeline Analysis
Chapter 4 T-cell Therapy Market Categorization: Therapy Type Estimates & Trend Analysis
                   4.1 T-cell Therapy Market: Therapy Type Movement Analysis
                   4.2 CAR T-cell Therapy
                       4.2.1 Global CAR T-cell Therapy market, 2018 - 2030 (USD Million)
                   4.3 T Cell Receptor (TCR)-based
                       4.3.1 Global T Cell Receptor (TCR)-based therapy market, 2018 - 2030 (USD Million)
                   4.4 Tumor Infiltrating Lymphocytes (TIL)-based
                       4.4.1 Global Tumor Infiltrating Lymphocytes (TIL)-based therapy market, 2018 - 2030 (USD Million)
Chapter 5 T-cell Therapy Market Categorization: Indication Estimates & Trend Analysis
                   5.1 T-cell Therapy Market: Indication Movement Analysis
                   5.2 Hematologic Malignancies
                       5.2.1 Global T-cell therapy market for hematologic malignancies, 2018 - 2030 (USD Million)
                       5.2.2 Lymphoma
                           5.2.2.1 Global T-cell therapy market for lymphoma, 2018 - 2030 (USD Million)
                       5.2.3 Leukemia
                           5.2.3.1 Global T-cell therapy market for leukemia, 2018 - 2030 (USD Million)
                       5.2.4 Myeloma
                           5.2.4.1 Global T-cell therapy market for myeloma, 2018 - 2030 (USD Million)
                   5.3 Solid Tumors
                       5.3.1 Global T-cell therapy market for solid tumors, 2018 - 2030 (USD Million)
                       5.3.2 Melanoma
                           5.3.2.1 Global T-cell therapy market for melanoma, 2018 - 2030 (USD Million)
                       5.3.3 Brain & Central Nervous System
                           5.3.3.1 Global T-cell therapy market for brain & central nervous system, 2018 - 2030 (USD Million)
                       5.3.4 Liver cancer
                           5.3.4.1 Global T-cell therapy market for liver cancer, 2018 - 2030 (USD Million)
                       5.3.5 Others
                           5.3.5.1 Global T-cell therapy market for other cancer forms, 2018 - 2030 (USD Million)
                   5.4 Others
                       5.4.1 Global T-cell therapy market for others, 2018 - 2030 (USD Million)
Chapter 6 T-cell Therapy Market Categorization: Regional Estimates & Trend Analysis, by Therapy Type & Indication
                   6.1 North America
                       6.1.1 SWOT Analysis
                           6.1.1.1 North America T-cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
                       6.1.2 U.S.
                           6.1.2.1 Key country dynamics
                           6.1.2.2 Target disease prevalence
                           6.1.2.3 Competitive scenario
                           6.1.2.4 Regulatory framework
                           6.1.2.5 Reimbursement scenario
                           6.1.2.6 U.S. T-cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
                       6.1.3 Canada
                           6.1.3.1 Key country dynamics
                           6.1.3.2 Target disease prevalence
                           6.1.3.3 Competitive scenario
                           6.1.3.4 Regulatory framework
                           6.1.3.5 Reimbursement scenario
                           6.1.3.6 Canada T-cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
                   6.2 Europe
                       6.2.1 SWOT Analysis:
                           6.2.1.1 Europe T-cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
                       6.2.2 Germany
                           6.2.2.1 Key country dynamics
                           6.2.2.2 Target disease prevalence
                           6.2.2.3 Competitive scenario
                           6.2.2.4 Regulatory framework
                           6.2.2.5 Reimbursement scenario
                           6.2.2.6 Germany T-cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
                       6.2.3 UK
                           6.2.3.1 Key country dynamics
                           6.2.3.2 Target disease prevalence
                           6.2.3.3 Competitive scenario
                           6.2.3.4 Regulatory framework
                           6.2.3.5 Reimbursement scenario
                           6.2.3.6 UK T-cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
                   6.3 Asia Pacific
                       6.3.1 SWOT analysis:
                           6.3.1.1 Key Region Dynamics
                           6.3.1.2 Asia Pacific T-cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
                       6.3.2 Japan
                           6.3.2.1 Target disease prevalence
                           6.3.2.2 Competitive scenario
                           6.3.2.3 Regulatory framework
                           6.3.2.4 Reimbursement scenario
                           6.3.2.5 Japan T-cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
                       6.3.3 China
                           6.3.3.1 Target disease prevalence
                           6.3.3.2 Competitive scenario
                           6.3.3.3 Regulatory framework
                           6.3.3.4 Reimbursement scenario
                           6.3.3.5 China T-cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
                   6.4 Rest Of The World
                       6.4.1 SWOT ANALYSIS:
                       6.4.2 KEY REGIONAL DYNAMICS
                           6.4.2.1 Rest of the World T-cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
Chapter 7 Competitive Landscape
                   7.1 Company Categorization
                   7.2 Company Market Share Analysis
                   7.3 Strategy Framework
                   7.4 Company Profiles
                       7.4.1 Novartis AG
                           7.4.1.1 Company overview
                               7.4.1.1.1 AveXis, Inc.
                           7.4.1.2 Financial performance
                           7.4.1.3 Product benchmarking
                           7.4.1.4 Strategic initiatives
                       7.4.2 Gilead Sciences
                           7.4.2.1 Company overview
                               7.4.1.1.1 Kite Pharma
                           7.4.2.2 Financial performance
                           7.4.2.3 Product benchmarking
                           7.4.2.4 Strategic initiatives
                       7.4.3 Bluebird bio, Inc.
                           7.4.3.1 Company overview
                           7.4.3.2 Financial performance
                           7.4.3.3 Product benchmarking
                           7.4.3.4 Strategic initiatives
                       7.4.4 TCR2 Therapeutics Inc
                           7.4.4.1 Company overview
                           7.4.4.2 Financial performance
                           7.4.4.3 Product benchmarking
                           7.4.4.4 Strategic initiatives
                       7.4.5 Sorrento Therapeutics
                           7.4.5.1 Company overview
                           7.4.5.2 Product benchmarking
                           7.4.5.3 Strategic initiatives
                       7.4.6 Fate Therapeutics
                           7.4.6.1 Company overview
                           7.4.6.2 Financial performance
                           7.4.6.3 Product benchmarking
                           7.4.6.4 Strategic initiatives
                       7.4.7 Merck KGaA
                           7.4.7.1 Company overview
                           7.4.7.2 Financial performance
                           7.4.7.3 Product benchmarking
                           7.4.7.4 Strategic initiatives
                       7.4.8 Pfizer Inc.
                           7.4.8.1 Company overview
                           7.4.8.2 Financial performance
                           7.4.8.3 Product benchmarking
                           7.4.8.4 Strategic initiatives
                       7.4.9 Amgen
                           7.4.9.1 Company overview
                           7.4.9.2 Financial performance
                           7.4.9.3 Product benchmarking
                           7.4.9.4 Strategic initiatives
                       7.4.10 Celgene Corporation
                           7.4.10.1 Company overview
                               7.4.10.1.1 Juno Therapeutics
                           7.4.10.2 Financial performance
                           7.4.10.3 Product benchmarking
                           7.4.10.4 Strategic initiatives


List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Global T-Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 4 Global T-Cell Therapy Market by Indication, 2018 - 2030 (USD Million)
TABLE 5 Global T-Cell Therapy Market by Region, 2018 - 2030 (USD Million)
TABLE 6 North America T-Cell Therapy Market by Country, 2018 - 2030 (USD Million)
TABLE 7 North America T-Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 8 North America T-Cell Therapy Market by Indication, 2018 - 2030 (USD Million)
TABLE 9 U.S. T-Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 10 U.S. T-Cell Therapy Market by Indication, 2018 - 2030 (USD Million)
TABLE 11 Canada T-Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 12 Canada T-Cell Therapy Market by Indication, 2018 - 2030 (USD Million)
TABLE 13 Europe T-Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 14 Europe T-Cell Therapy Market by Indication, 2018 - 2030 (USD Million)
TABLE 15 Germany T-Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 16 Germany T-Cell Therapy Market by Indication, 2018 - 2030 (USD Million)
TABLE 17 UK T-Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 18 UK T-Cell Therapy Market by Indication, 2018 - 2030 (USD Million)
TABLE 19 Asia Pacific T-Cell Therapy Market by Country, 2018 - 2030 (USD Million)
TABLE 20 Asia Pacific T-Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 21 Asia Pacific T-Cell Therapy Market by Indication, 2018 - 2030 (USD Million)
TABLE 22 China T-Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 23 China T-Cell Therapy Market by Indication, 2018 - 2030 (USD Million)
TABLE 24 Japan T-Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 25 Japan T-Cell Therapy Market by Indication, 2018 - 2030 (USD Million)
TABLE 26 Rest Of The World T-Cell Therapy Market by Country, 2018 - 2030 (USD Million)
TABLE 27 Rest Of The World T-Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 28 Rest Of The World T-Cell Therapy Market by Indication, 2018 - 2030 (USD Million)


List of Figures

FIG. 1 Information Procurement
FIG. 2 Primary Research Pattern
FIG. 3 Market Research Approaches
FIG. 4 Value Chain-Based Sizing & Forecasting
FIG. 5 Market Formulation & Validation
FIG. 6 T-Cell Therapy, Market Segmentation
FIG. 7 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 8 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 9 Market Opportunity Relevance Analysis (Current & Future Impact)
FIG. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 11 Porter’s Five Forces Analysis
FIG. 12 Global T-Cell Therapy Market for CAR T Cell Therapy,2018 - 2030 (USD Million)
FIG. 13 Global T-Cell Therapy Market for T Cell Receptor (TCR)-based,2018 - 2030 (USD Million)
FIG. 14 Global T-Cell Therapy Market for Tumor Infiltrating Lymphocytes (TIL)-based,2018 - 2030 (USD Million)
FIG. 15 Global T-Cell Therapy Market for Hematologic Malignancies,2018 - 2030 (USD Million)
FIG. 16 Global T-Cell Therapy Market for Lymphoma,2018 - 2030 (USD Million)
FIG. 17 Global T-Cell Therapy Market for Leukemia , 2018 - 2030 (USD Million)
FIG. 18 Global T-Cell Therapy Market for Myeloma,2018 - 2030 (USD Million)
FIG. 19 Global T-Cell Therapy Market for Solid Tumors,2018 - 2030 (USD Million)
FIG. 20 Global T-Cell Therapy Market for Melanoma , 2018 - 2030 (USD Million)
FIG. 21 Global T-Cell Therapy Market for Brain and central nervous system,2018 - 2030 (USD Million)
FIG. 22 Global T-Cell Therapy Market for Liver cancer,2018 - 2030 (USD Million)
FIG. 23 Global T-Cell Therapy Market for Other Indications,2018 - 2030 (USD Million)
FIG. 24 Regional Outlook, 2021 & 2030
FIG. 25 North America T-Cell Therapy Market 2018 - 2030 (USD Million)
FIG. 26 U.S. T-Cell Therapy Market 2018 - 2030 (USD Million)
FIG. 27 Canada T-Cell Therapy Market 2018 - 2030 (USD Million)
FIG. 28 Europe T-Cell Therapy Market 2018 - 2030 (USD Million)
FIG. 29 Germany T-Cell Therapy Market 2018 - 2030 (USD Million)
FIG. 30 UK T-Cell Therapy Market 2018 - 2030 (USD Million)
FIG. 31 Asia Pacific T-Cell Therapy Market 2018 - 2030 (USD Million)
FIG. 32 Japan T-Cell Therapy Market 2018 - 2030 (USD Million)
FIG. 33 China T-Cell Therapy Market 2018 - 2030 (USD Million)
FIG. 34 Rest Of The World T-Cell Therapy Market 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon